SVB Leerink Downgrades Millendo Therapeutics Inc. (MLND) to Market Perform

January 6, 2021 1:43 AM EST Send to a Friend
SVB Leerink analyst Joseph Schwartz downgraded Millendo Therapeutics Inc. (NASDAQ: MLND) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login